Related Experiment Video
Updated: Jul 5, 2026

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
Multiple organ system extracorporeal support in critically ill children
1Pediatric Critical Care, Children's Hospital of Pittsburgh, 3705 Fifth Ave., Pittsburgh, PA 15213, USA. carcilloja@ccm.upmc.edu
Insights
Extracorporeal support aids failing organs in critically ill children. Optimal outcomes require reversible disease, expert care minimizing hemolysis, and goal-directed therapy.
Area of Science:
- Pediatric Critical Care Medicine
- Extracorporeal Therapies
Background:
- Multiple organ system failure (MOSF) is a critical condition in infants and children.
- Extracorporeal support offers vital organ function replacement.
Purpose of the Study:
- To provide a framework for implementing multidisciplinary team approaches for extracorporeal support in pediatric MOSF.
- To highlight key factors for optimizing extracorporeal therapy benefits.
Main Methods:
- Review of extracorporeal support modalities for pediatric MOSF.
- Framework development for multidisciplinary team implementation.
- Emphasis on expert management and goal-directed therapy.
Main Results:
- Extracorporeal support effectively sustains brain, heart, lung, liver, and kidney function.
- Support extends to coagulation, red blood cell, and immune cell functions.
- Successful application depends on reversible underlying disease and expert, monitored therapy.
Conclusions:
- Extracorporeal support is a significant advancement in pediatric critical care.
- Expertise, hemolysis prevention, and goal-directed approaches are crucial for optimal outcomes.
- A multidisciplinary team approach is essential for effective implementation.
Abstract:
Multiple organ system extracorporeal support effectively supports brain, heart, lung, liver, kidney, coagulation, red blood cell, and immune cell function in the sickest infants and children who have multiple organ system failure. These therapies have optimum benefit if: (1) the underlying disease is reversible; (2) the therapies are performed expertly and are monitored to prevent and minimize systemic hemolysis; and (3) the therapies are provided in a goal-directed manner. These therapies represent a significant advance in pediatric critical care medicine. This article provides a framework for this multidisciplinary team approach for implementing these therapies.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Kidney Transplant I: Introduction
